LPA Antikörper
(2 Referenzen)-
- Target Alle LPA (APOA) Antikörper anzeigen
- LPA (APOA) (Apolipoprotein A (APOA))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser LPA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Aufreinigung
- Ascitic fluid
- Immunogen
- Purified recombinant fragment of LPA (4330-4521) expressed in E. Coli.
- Klon
- 8F6A9-8H5C5
- Isotyp
- IgG1
- Top Product
- Discover our top product APOA Primärantikörper
-
anti-Apolipoprotein A (APOA) (AA 4330-4521) antibody
APOA Reaktivität: Human WB, ELISA, IHC, ICC Wirt: Maus Monoclonal 4H1 unconjugated
anti-Apolipoprotein A (APOA) antibodyAPOA Reaktivität: Human WB, ELISA, IHC, IF, IHC (p) Wirt: Maus Monoclonal 4H1 unconjugated
anti-Apolipoprotein A (APOA) (AA 4330-4521) antibodyAPOA Reaktivität: Human WB, ELISA, IHC, IF/ICC Wirt: Maus Monoclonal unconjugated
anti-Apolipoprotein A (APOA) (AA 1719-2038) antibodyAPOA Reaktivität: Human WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A (APOA) (AA 3653-3702) antibodyAPOA Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A (APOA) (AA 3962-4011) antibodyAPOA Reaktivität: Human, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A (APOA) (N-Term) antibodyAPOA Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
Western Bloting: 1/500 - 1/2000.
Immunohistochemistry: 1/200 - 1/1000.
ELISA: Propose dilution 1/10000.
Not yet tested in other applications.
Determining optimal working dilutions by titration test. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
-
-
"USA: bringing reality to the great American tobacco show." in: Tobacco control, Vol. 16, Issue 4, pp. 220-1, (2007) (PubMed).
: "The LPA gene C93T polymorphism influences plasma lipoprotein(a) levels and is independently associated with susceptibility to peripheral arterial disease." in: Clinica chimica acta; international journal of clinical chemistry, Vol. 387, Issue 1-2, pp. 109-12, (2007) (PubMed).
-
"USA: bringing reality to the great American tobacco show." in: Tobacco control, Vol. 16, Issue 4, pp. 220-1, (2007) (PubMed).
-
- Target
- LPA (APOA) (Apolipoprotein A (APOA))
- Andere Bezeichnung
- LPA (APOA Produkte)
- Synonyme
- AK38 antikoerper, APOA antikoerper, LP antikoerper, Apo(a) antikoerper, Lp(a) antikoerper, lipoprotein(a) antikoerper, LPA antikoerper
- Hintergrund
-
LPA: lipoprotein, Lp(a). Apo(a) is the main constituent of lipoprotein(a) (lp(a)). It has serine proteinase activity and is able of autoproteolysis. Inhibits tissue-type plasminogen activator 1.Lp(a) may be a ligand for megalin/gp 330.Apo(a) is known to be proteolytically cleaved, leading to the formation of the so-called mini-lp(a).Apo(a) fragments accumulate in atherosclerotic lesions,where they may promote thrombogenesis.O-glycosylation may limit the extent of proteolytic fragmentation.
Synonyms: LP, AK38, APOA, LPA - Gen-ID
- 4018
-
